US Patent 7141572 Hydrazono-malonitriles
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Hans-Michael Eggenweiler0
Michael Wolf0
Norbert Beier0
Pierre Schelling0
Thomas Ehring0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+418 characters)
Article
Patent abstract
Hydrazono-malonitrile derivatives of the formula (I) in which R1, R2, R3, R3′ and R4 have the meanings given in Claim 1 act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07141572 Hydrazono-malonitriles US Patent 7141572 Hydrazono-malonitriles
Infobox
Patent Number
071415720
Patent Number
71415720
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
071415720
Date of Patent
November 28, 2006
0Patent Application Number
104946310
Date Filed
October 10, 2002
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 19 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07141572 Hydrazono-malonitriles
Infobox
Is a
Patent jurisdiction
Patent number
07141572
Date of patent
November 28, 2006
Patent application number
10494631
Date Filed
October 10, 2002
Patent primary examiner
Find more entities like US Patent 7141572 Hydrazono-malonitriles
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.